Legend Biotech Corp Adr (LEGN)

04:12 AM

iShares MBS ETF $MBB Shares Acquired by Capital International Investors - Defense World

04:12 AM

04:11 AM

CLEAR Secure, Inc. (NYSE:YOU) Receives Average Recommendation of “Hold” from Analysts - Defense World

04:11 AM

Mar 12, 2026

Legend Biotech Plans to List in HK as Early as This Yr, Raising at Least US$300M: Wire - AASTOCKS.com

Mar 12, 2026

Mar 11, 2026

RBC Capital lowers Legend Biotech stock price target on model updates By Investing.com - Investing.com South Africa

Mar 11, 2026

Mar 11, 2026

RBC Capital lowers Legend Biotech stock price target on model updates - Investing.com India

Mar 11, 2026

Mar 10, 2026

Raymond James reiterates Legend Biotech stock rating on strong Q4 results By Investing.com - Investing.com India

Mar 10, 2026

Mar 10, 2026

Truist reiterates Buy on Legend Biotech stock, $70 target on capacity - Investing.com

Mar 10, 2026

Mar 10, 2026

Jefferies reiterates Legend Biotech stock rating on Carvykti sales By Investing.com - Investing.com India

Mar 10, 2026

Mar 10, 2026

Legend Biotech Q4 Earnings Call Highlights - Yahoo Finance

Mar 10, 2026

Mar 10, 2026

Legend Biotech Q4 2025 slides: CARVYKTI turns profitable, $555M sales - Investing.com India

Mar 10, 2026

Mar 10, 2026

Earnings call transcript: Legend Biotech Q4 2025 shows strong growth - Investing.com

Mar 10, 2026

Mar 10, 2026

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Mar 10, 2026

Mar 09, 2026

Legend Biotech earnings on deck as profitability looms - Investing.com South Africa

Mar 09, 2026

Mar 08, 2026

Triata Capital Ltd Purchases 54,300 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat

Mar 08, 2026

Mar 06, 2026

Raymond James reiterates Legend Biotech stock rating after rival approval - Investing.com

Mar 06, 2026

Mar 06, 2026

Legend Biotech (NASDAQ:LEGN) Trading Up 5.5%Here's Why - MarketBeat

Mar 06, 2026

Feb 28, 2026

Artisan Partners Limited Partnership Purchases 425,684 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat

Feb 28, 2026

Feb 26, 2026

Westfield Capital Management Co. LP Lowers Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat

Feb 26, 2026

Feb 23, 2026

Raymond James reiterates Legend Biotech stock rating on valuation gap - Investing.com South Africa

Feb 23, 2026

Feb 18, 2026

Barclays Cite Favorable Long-Term Outlook For Legend Biotech Corporation (LEGN) Despite Near-Term Expectation Revisions - Finviz

Feb 18, 2026

Feb 16, 2026

FDA Guidance on MRD Negativity Bodes Well for Legend Biotech (LEGN) - Finviz

Feb 16, 2026

Feb 13, 2026

Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Feb 13, 2026

Feb 13, 2026

Legend Biotech (NASDAQ:LEGN) Downgraded by Rothschild & Co Redburn to “Neutral” - Defense World

Feb 13, 2026

Feb 12, 2026

Legend Biotech stock rating downgraded by Rothschild Redburn on competition concerns By Investing.com - Investing.com India

Feb 12, 2026

Feb 12, 2026

Legend Biotech stock rating downgraded by Rothschild Redburn on competition concerns - Investing.com

Feb 12, 2026

Feb 12, 2026

Legend Biotech (NASDAQ:LEGN) Makes Strides in Nasdaq Composite Biotech Field - Kalkine Media

Feb 12, 2026

Feb 10, 2026

Investment Analysts’ Weekly Ratings Updates for Legend Biotech (LEGN) - Defense World

Feb 10, 2026

Feb 07, 2026

Legend Biotech (LEGN) Shakes Up Board - Finviz

Feb 07, 2026

Feb 03, 2026

Legend Biotech (NASDAQ:LEGN) Sets New 12-Month LowTime to Sell? - MarketBeat

Feb 03, 2026

Feb 02, 2026

H.C. Wainwright Highlight Curative Potential of Legend Biotech Corporation (LEGN)'s Carvykti Despite Sales Miss - Finviz

Feb 02, 2026

Feb 01, 2026

82,516 Shares in Legend Biotech Corporation Sponsored ADR $LEGN Bought by Mutual of America Capital Management LLC - MarketBeat

Feb 01, 2026

Jan 28, 2026

Legend Biotech stock hits 52-week low at $18.07 By Investing.com - Investing.com South Africa

Jan 28, 2026

Jan 28, 2026

Legend Biotech stock hits 52-week low at $18.07 - Investing.com

Jan 28, 2026

Jan 27, 2026

Legend Biotech (NASDAQ:LEGN) Hits New 12-Month LowTime to Sell? - MarketBeat

Jan 27, 2026

Jan 26, 2026

Legend Biotech (LEGN) Advances Cell Therapy Innovation and Expands Oncology Pipeline - Finviz

Jan 26, 2026

Jan 26, 2026

Legend Biotech FY2025 EPS Estimate Lifted by HC Wainwright - MarketBeat

Jan 26, 2026

Jan 23, 2026

Legend Biotech (NASDAQ:LEGN) Price Target Lowered to $50.00 at HC Wainwright - Defense World

Jan 23, 2026

Jan 23, 2026

Legend Biotech (NASDAQ:LEGN) Shares Gap Down on Analyst Downgrade - Defense World

Jan 23, 2026

Jan 22, 2026

H.C. Wainwright lowers Legend Biotech stock price target on Q4 sales miss By Investing.com - Investing.com South Africa

Jan 22, 2026

Jan 22, 2026

H.C. Wainwright lowers Legend Biotech stock price target on Q4 sales miss - Investing.com India

Jan 22, 2026

Jan 22, 2026

Rakuten Investment Management Inc. Takes $7.58 Million Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat

Jan 22, 2026

Jan 22, 2026

Legend Biotech stock rating downgraded by TD Cowen on Carvykti concerns - Investing.com South Africa

Jan 22, 2026

Jan 22, 2026

Legend Biotech stock hits 52-week low at $20.15 By Investing.com - Investing.com India

Jan 22, 2026

Jan 21, 2026

Legend Biotech (NASDAQ:LEGN) Hits New 52-Week LowHere's Why - MarketBeat

Jan 21, 2026

Jan 21, 2026

Legend Biotech stock hits 52-week low at $20.15 - Investing.com

Jan 21, 2026

Jan 21, 2026

Legend Biotech (NASDAQ:LEGN) Given “Outperform” Rating at Royal Bank Of Canada - Defense World

Jan 21, 2026

Jan 20, 2026

Raymond James reiterates Outperform rating on Legend Biotech stock By Investing.com - Investing.com India

Jan 20, 2026

Jan 20, 2026

Raymond James reiterates Outperform rating on Legend Biotech stock - Investing.com

Jan 20, 2026

Jan 20, 2026

Legend Biotech stock rises as FDA draft guidance supports accelerated approval endpoints By Investing.com - Investing.com South Africa

Jan 20, 2026

Jan 20, 2026

Legend Biotech stock rises as FDA draft guidance supports accelerated approval endpoints - Investing.com

Jan 20, 2026